Progress in understanding of relationship between nephrostasis and hypertension

doi:10.3877/cma.j.issn.1674-0785.2022.12.023

Abstract

Abstract:

Kidney stones can lead to the development of new-onset hypertension and accelerate its progression; hypertension, in turn, is a risk factor for kidney stones. Since there are common pathways and certain links between the development of both, this paper reviews the possible links between the two in terms of high urinary calcium, insulin resistance, inflammation, and cytokines, as well as oxidative stress and surgery, in order to provide some feasible ideas for better prevention of these diseases and their future research.

Key words: Kidney stones, Hypertension, Calcium metabolism, Insulin resistance, Oxidative stress

Xiaoxiao Jin, Cong Zheng, Wenqiang He. Progress in understanding of relationship between nephrostasis and hypertension[J]. Chinese Journal of Clinicians(Electronic Edition), 2022, 16(12): 1284-1288.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhlcyszz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0785.2022.12.023

https://zhlcyszz.cma-cmc.com.cn/EN/Y2022/V16/I12/1284

Figures/Tables 3

References 48

1	Khan SR, Pearle MS, Robertson WG, et al. Kidney stones [J]. Nat Rev Dis Primers, 2016, 2: 16008.
2	Wiener SV, Ho SP, Stoller ML. Beginnings of nephrolithiasis: insights into the past, present and future of Randall's plaque formation research [J]. Curr Opin Nephrol Hypertens, 2018, 27(4): 236-242.
3	李永超, 李杨. 肾结石Randall斑块研究进展 [J]. 中南大学学报(医学版), 2020, 45(4): 435-439.
4	Zeng G, Mai Z, Xia S, et al. Prevalence of kidney stones in China: an ultrasonography based cross-sectional study [J]. BJU Int, 2017, 120(1): 109-116.
5	Romero V, Akpinar H, Assimos DG. Kidney stones: a global picture of prevalence, incidence, and associated risk factors [J]. Rev Urol, 2010, 12(2-3): e86-96.
6	Ping H, Lu N, Wang M, et al. New-onset metabolic risk factors and the incidence of kidney stones: a prospective cohort study [J]. BJU Int, 2019, 124(6): 1028-1033.
7	Kittanamongkolchai W, Mara KC, Mehta RA, et al. Risk of hypertension among first-time symptomatic kidney stone formers [J]. Clin J Am Soc Nephrol, 2017, 12(3): 476-482.
8	Shang W, Li Y, Ren Y, et al. Nephrolithiasis and risk of hypertension: a meta-analysis of observational studies [J]. BMC Nephrol, 2017, 18(1):344.
9	Eisner BH, Porten SP, Bechis SK, et al. Hypertension is associated with increased urinary calcium excretion in patients with nephrolithiasis [J]. J Urol, 2010, 183(2): 576-579.
10	靳潇潇, 何文强. 含钙肾结石与骨密度之间关系的研究现状 [J]. 中国骨质疏松杂志, 2021, 27(2): 303-307.
11	Borghi L, Schianchi T, Meschi T, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria [J]. N Engl J Med, 2002, 346(2): 77-84.
12	Nouvenne A, Meschi T, Prati B, et al. Effects of a low-salt diet on idiopathic hypercalciuria in calcium-oxalate stone formers: a 3-mo randomized controlled trial [J]. Am J Clin Nutr, 2010, 91(3): 565-570.
13	Hartman C, Friedlander JI, Moreira DM, et al. Does hypertension impact 24-hour urine parameters in patients with nephrolithiasis? [J]. Urology, 2015, 85(3): 539-543.
14	Kohjimoto Y, Sasaki Y, Iguchi M, et al. Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan [J]. Am J Kidney Dis, 2013, 61(6): 923-929.
15	Liu YT, Yang PY, Yang YW, et al. The association of nephrolithiasis with metabolic syndrome and its components: a cross-sectional analysis [J]. Ther Clin Risk Manag, 2017, 13: 41-48.
16	Zafar U, Khaliq S, Ahmad HU, et al. Metabolic syndrome: an update on diagnostic criteria, pathogenesis, and genetic links [J]. Hormones, 2018, 17(3): 299-313.
17	Brown A E, Walker M. Genetics of insulin resistance and the metabolic syndrome [J]. Curr Cardiol Rep, 2016, 18(8): 75.
18	Strohmaier WL, Wrobel BM, Schubert G. Overweight, insulin resistance and blood pressure (parameters of the metabolic syndrome) in uric acid urolithiasis [J]. Urol Res, 2012, 40(2): 171-175.
19	Evan AP, Worcester EM, Coe FL, et al. Mechanisms of human kidney stone formation [J]. Urolithiasis, 2015, 43 Suppl 1(0 1):19-32.
20	Esteghamat F, Broughton JS, Smith E, et al. CELA2A mutations predispose to early-onset atherosclerosis and metabolic syndrome and affect plasma insulin and platelet activation [J]. Nat Genet, 2019, 51(8): 1233-1243.
21	Khan SR, Canales BK, Dominguez-Gutierrez PR. Randall's plaque and calcium oxalate stone formation: role for immunity and inflammation [J]. Nat Rev Nephrol, 2021, 17(6): 417-433.
22	Yang H, Xie T, Li D, et al. Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-κB/TNF-α pathway [J]. Mol Metab, 2019, 23: 24-36.
23	Schmidt-Arras D, Rose-John S. IL-6 pathway in the liver: from physiopathology to therapy [J]. J Hepatol, 2016, 64(6): 1403-1415.
24	Zhang X, Fan L, Wu J, et al. Macrophage p38α promotes nutritional steatohepatitis through M1 polarization [J]. J Hepatol, 2019, 71(1): 163-174.
25	Org E, Blum Y, Kasela S, et al. Relationships between gut microbiota, plasma metabolites, and metabolic syndrome traits in the METSIM cohort [J]. Genome Biol, 2017, 18(1): 70.
26	Ma MC, Chen YS, Huang HS. Erythrocyte oxidative stress in patients with calcium oxalate stones correlates with stone size and renal tubular damage [J]. Urology, 2014, 83(2): 510 e9-17.
27	Joshi S, Khan SR. Opportunities for future therapeutic interventions for hyperoxaluria: targeting oxidative stress [J]. Expert Opin Ther Targets, 2019, 23(5): 379-391.
28	叶涛, 叶章群. 炎症和氧化应激反应与肾结石形成的研究进展 [J]. 中华泌尿外科杂志, 2018, 39(9): 711-713.
29	Wang Y, Sun C, Li C, et al. Urinary MCP-1、HMGB1 increased in calcium nephrolithiasis patients and the influence of hypercalciuria on the production of the two cytokines [J]. Urolithiasis, 2017, 45(2): 159-175.
30	Fukumoto J, Fukumoto I, Parthasarathy PT, et al. NLRP3 deletion protects from hyperoxia-induced acute lung injury [J]. Am J Physiol Cell Physiol, 2013, 305(2): C182-C189.
31	Mulay S R, Kulkarni O P, Rupanagudi K V, et al. Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1β secretion [J]. J Clin Invest, 2013, 123(1): 236-246.
32	Umekawa T, Hatanaka Y, Kurita T, et al. Effect of angiotensin II receptor blockage on osteopontin expression and calcium oxalate crystal deposition in rat kidneys [J]. J Am Soc Nephrol, 2004, 15(3): 635-644.
33	Dominguez-Gutierrez PR, Kusmartsev S, Canales BK, et al. Calcium oxalate differentiates human monocytes into inflammatory M1 macrophages [J]. Front Immunol, 2018, 9: 1863.
34	Liu Q, Liu Y, Guan X, et al. Effect of M2 macrophages on injury and apoptosis of renal tubular epithelial cells induced by calcium oxalate crystals [J]. Kidney Blood Press Res, 2019, 44(4): 777-791.
35	Small H Y, Migliarino S, Czesnikiewicz-Guzik M, et al. Hypertension: focus on autoimmunity and oxidative stress [J]. Free Radic Biol Med, 2018, 125: 104-115.
36	Wilcox CS. Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension? [J]. Am J Physiol Regul Integr Comp Physiol, 2005, 289(4): R913-R935.
37	Montezano AC, Dulak-Lis M, Tsiropoulou S, et al. Oxidative stress and human hypertension: vascular mechanisms, biomarkers, and novel therapies [J]. Can J Cardiol, 2015, 31(5): 631-641.
38	陈颖妹, 马建林. 同型半胱氨酸、氧化应激与高血压关系的研究进展 [J]. 中国循证心血管医学杂志, 2020, 12(7): 895-896.
39	Rudemiller NP, Crowley SD. Interactions between the immune and the renin-angiotensin systems in hypertension [J]. Hypertension, 2016, 68(2): 289-296.
40	Justin Rucker A, Crowley SD. The role of macrophages in hypertension and its complications [J]. Pflugers Arch, 2017, 469(3-4): 419-430.
41	Chien TM, Lu YM, Chou YH, et al. Percutaneous nephrolithotomy increases the risk of new-onset hypertension: a nationwide 6-year follow-up study [J]. Urology, 2016, 97: 61-65.
42	Lu YM, Chien TM, Chou YH, et al. Is extracorporeal shock wave lithotripsy really safe in long-term follow-up? a nationwide retrospective 6-year age-matched non-randomized study [J]. Urol Int, 2017, 98(4): 397-402.
43	Ng CF, Luke S, Yee CH, et al. Extracorporeal shockwave lithotripsy could lead to a prolonged increase in the renal fibrotic process of up to 2 years [J]. J Endourol, 2018, 32(3): 223-229.
44	Fankhauser CD, Kranzbühler B, Poyet C, et al. Long-term adverse effects of extracorporeal shock-wave lithotripsy for nephrolithiasis and ureterolithiasis: a systematic review [J]. Urology, 2015, 85(5): 991-1006.
45	Qin B, Wang Q, Lu Y, et al. Losartan ameliorates calcium oxalate-induced elevation of stone-related proteins in renal tubular cells by Inhibiting NADPH oxidase and oxidative stress [J]. Oxid Med Cell Longev, 2018: 1271864.
46	Zhu J, Wang Q, Li C, et al. Inhibiting inflammation and modulating oxidative stress in oxalate-induced nephrolithiasis with the Nrf2 activator dimethyl fumarate [J]. Free Radic Biol Med, 2019, 134: 9-22.
47	庞翀, 陈群娟. 缬沙坦联合富马酸比索洛尔对老年高血压心脏病患者相关生化指标、炎症因子及氧化应激水平的影响 [J]. 中国老年学杂志, 2021, 41(4): 673-676.
48	Alexander RT, Mcarthur E, Jandoc R, et al. Antihypertensive medications and the risk of kidney stones in older adults: a retrospective cohort study [J]. Hypertens Res, 2017, 40(9): 837-842.

[1]	Xiya Jin, Xiaosong Huang, Cheng Tan, Qin Jiang, Fang Hou, Yaoyue Li, Bing Xu, Honghui Jia, Wenying Liu. Antenatal treatment of tacrolimus on pulmonary vascular remodeling in rat with experimental pathological model of congenital diaphragmatic hernia [J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(04): 428-436.
[2]	Peng Zheng, Saiping Wu, Xiuzhang Xie, Qingfeng Shi. Construction and validation of a nomogram model for predicting infectious kidney stones before surgery [J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2023, 17(05): 299-306.
[3]	Jianmei Li, Jingjuan Deng, Qian Yang. Safety and follow-up evaluation of the combined treatment of hepatocellular carcinoma with hepatic cirrhosis and portal hypertension [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 41-44.
[4]	zhi Cao, Xiwang Zhu, Wei Wang, Hui Zhang, Chenglin Yang, Xiaoming Zhang. Correlation between different renal pellis pressures and perioperative complications during percutaneous nephrolithotomy [J]. Chinese Journal of Endourology(Electronic Edition), 2023, 17(06): 616-620.
[5]	Jun Liu, Ji Zhu, Jun Yin. Anesthesia effect and safety of dexmedetomidine in inguinal hernia surgery [J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2023, 17(05): 570-573.
[6]	Qikun Zhang, Fuchao Shang, Qi Li, Guangming Li, Menglong Wang. Survival benefit of combined splenectomy in patients with liver cancer complicated with portal hypertension after radical resection [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(06): 613-618.
[7]	Haiyan Chen, Huimin Zhou, Jiaqi Cui. Moderate severe acute pancreatitis following transurethral cystoscopic holmium laser lithotripsy: report of one case [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(04): 461-463.
[8]	Yuyang Xu, Yunfu Lyu, Baochun Wang. Progress of surgical treatments for splenomegaly in patients with hepatitis B cirrhotic portal hypertension [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(04): 469-473.
[9]	Rong He, Zhe Jia, Ke Zhang, Daijing Li, Meng Zhang, Li Jiang. Analysis of clinical efficacy of laparoscopic hepatectomy combined with Hassab's procedure for primary liver cancer complicated with portal hypertension based on propensity score matching [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(04): 376-383.
[10]	Huijuan Shang, Xiaodong Yuan. Improvement of prognosis of acute cerebral ischemic stroke with edaravone dexkanol after mechanical thrombectomy [J]. Chinese Journal of Neurotraumatic Surgery(Electronic Edition), 2023, 09(05): 295-301.
[11]	Yong Zou, Yingjiang Gu, Hao Ding, Chenghao Yang, Minhui Chen, Yu Cai. Effects of puerarin on early inflammatory and oxidative stress responses involving the Nrf2/HO-1 and NF-κB signaling pathways after intracerebral hemorrhage in rat models [J]. Chinese Journal of Brain Diseases and Rehabilitation(Electronic Edition), 2023, 13(05): 271-277.
[12]	Xiulan Xu, Jianjian Zhu. Clinical relationship between blood pressure variability and poor prognosis in patients with acute cerebral infarction and H-type hypertension [J]. Chinese Journal of Brain Diseases and Rehabilitation(Electronic Edition), 2023, 13(04): 199-204.
[13]	Minjie Zhang, Xiaoshan Zhang, Shasha Duan, Yilu Shi, Jie Zhao, Tianhao Bai, Yaxi Wang. Hydrogen for treatment of myocardial ischemia-reperfusion injury: mechanism and prospect [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(06): 744-748.
[14]	Linyang Yu, Meiying Wang, Jianbin Li, Xiaobin Lou, Siyuan Xie, Zhizhong Ma, Haiying Qi, Jia Li. Characteristics of pulmonary arterial pressure and cardiac morphology and function in children with pneumonia and right heart failure in a high altitude area [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(05): 535-544.
[15]	Qianxue Yu, Xuemei Liao, Longlong Sun, Mengying Fan, Mingchao Jiang, Hui Meng, Ruiji Li. Research progress of mitochondrial dysfunction and premature ovarian failure [J]. Chinese Journal of Diagnostics(Electronic Edition), 2023, 11(04): 283-288.

Please choose a citation manager

Content to export